Announcement on Convening the Q3 2026 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688289)"Sansure Biotech Inc."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688289 ·
On 6ix: 6ix.com/news/688289sansure-biotech-incannouncement-on-convening-the-q3-2026-performance-briefing
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Sansure Biotech Inc. on 6ix
Story so far
- (688289)"Sansure Biotech Inc."Announcement on Issuance Results of the 1st Tranche of Medium-term Notes for 2026
- (688289)"Sansure Biotech Inc."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2021 Restricted Share Incentive Plan
- (688289)"Sansure Biotech Inc."Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
Earlier from Sansure Biotech
- (688289)"Sansure Biotech Inc."Announcement on Issuance Results of the 1st Tranche of Medium-term Notes for 2026
- (688289)"Sansure Biotech Inc."Announcement on Satisfaction of Vesting Conditions for the Fourth Vesting Period of Initial Grant and the Third Vesting Period of Reserved Grant under the 2021 Restricted Share Incentive Plan
- (688289)"Sansure Biotech Inc."Announcement on Resolutions of the 9th Extraordinary Meeting of the 3rd Board of Directors in 2026
- (688289)"Sansure Biotech Inc."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2021 Restricted Share Incentive Plan
- (688289)"Sansure Biotech Inc."Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
Follow Sansure Biotech into a list and get an email when it puts out news.
Follow Sansure Biotech